Background The fundamental determinant of the natural history of Chagas' disease is cardiac involvement.
Methods and Results We studied 104 male patients with congestive heart failure due to Chagas' there has been a great development in its understanding through research in several fields. The fundamental determinant of the natural history of the disease is cardiac involvement, and its several evolutive forms have been well studied from the morphological, etiopathogenic, and clinical points of view.2 7 However, studies regarding functional alterations are rare, and when performed, they were generally restricted to patients with advanced congestive heart failure (CHF); the milder forms deserved less attention.6 13 1 and 77 months (30.1±24.5, median of 24 months). All patients were treated and followed up in our hospital, and they received digitalis, diuretics, and vasodilator drugs whenever necessary and in the absence of side effects. Patients were not submitted to cardiomyoplasty and heart transplantation until the end of the study.
The diagnosis of Chagas' disease was based on epidemiological aspects, clinical history, physical findings compatible with cardiomyopathy, serological reactions (Machado-Guerreiro and immunofluorescence), and typical ECG abnormalities. The latter included 30 electrically inactive areas, 61 right bundle branch blocks, 49 left anterosuperior division branch blocks, 2 posteroinferior division branch blocks, 2 anteromedial division branch blocks, 6 left ventricular hypertrophies, 42 ventricular extrasystoles, 22 supraventricular extrasystoles, 5 first-degree atrioventricular (AV) blocks, 1 with second-degree AV block Mobitz type I, 2 left bundle branch blocks, and 9 atrial fibrillations. Patients with high-degree AV block were excluded.
The proposition was to study these patients in relation to survival and to evaluate age, FC, maximal oxygen consumption (Vo2max), and ejection fraction (EF) as predictors of survival.
The EF was obtained by Aloka SSD 720 and SSd 870 echocardiographic equipment and was calculated by the formula EF=EDV-ESV/EDV, in which EDV is the end-diastolic volume and ESV is the end-systolic volume. 16 The volumes were calculated by the formula of Pombo in accordance with the American Society of Echocardiography,16 and the mean of five consecutive beats was used.
The evaluation of the Vo2max was performed using a Beckman computerized gas analyzer, model MMC, which has a polarographic sensor (OM-11) and an infrared system In our patients, we found overall survival rates of 66% at 1 year, 56% at 3 years, and 48% at 5 years (Fig  1) . However, when we divided the patients into subgroups according to FC, we noticed a clear relation between symptoms and mortality, showing an important prognostic significance (Fig 2) .
Patients in FC II had the same predicted survival probability of 97% at 1 year and 3 years, demonstrating the good prognosis of this subgroup. Patients in FC III had predicted survival probabilities of 73% in 1 year and 58% in 3 years. Patients in FC IV had a considerably lower predicted survival rates, 38% at 1 year and 16% at 3 years (Fig 2) 
